
The following have been reloaded with a version change:
  1) GCCcore/8.3.0 => GCCcore/9.3.0
  2) binutils/2.32-GCCcore-8.3.0 => binutils/2.34-GCCcore-9.3.0
  3) zlib/1.2.11-GCCcore-8.3.0 => zlib/1.2.11-GCCcore-9.3.0

2021-02-01 00:30:13 | INFO | fairseq_cli.train | Namespace(activation_dropout=0.0, activation_fn='relu', adam_betas='(0.9, 0.98)', adam_eps=1e-08, adaptive_input=False, adaptive_softmax_cutoff=None, adaptive_softmax_dropout=0, all_gather_list_size=16384, arch='transformer_vaswani_wmt_en_de_big', attention_dropout=0.0, best_checkpoint_metric='loss', bf16=False, bpe=None, broadcast_buffers=False, bucket_cap_mb=25, checkpoint_suffix='', clip_norm=0.0, cpu=False, criterion='label_smoothed_cross_entropy', cross_self_attention=False, curriculum=0, data='../../../data-bin/custom_EMEA/orig_EMEA', data_buffer_size=10, dataset_impl=None, ddp_backend='c10d', decoder_attention_heads=16, decoder_embed_dim=1024, decoder_embed_path=None, decoder_ffn_embed_dim=4096, decoder_input_dim=1024, decoder_layerdrop=0, decoder_layers=6, decoder_layers_to_keep=None, decoder_learned_pos=False, decoder_normalize_before=False, decoder_output_dim=1024, device_id=0, disable_validation=False, distributed_backend='nccl', distributed_init_method=None, distributed_no_spawn=False, distributed_port=-1, distributed_rank=0, distributed_world_size=1, distributed_wrapper='DDP', dropout=0.2, empty_cache_freq=0, encoder_attention_heads=16, encoder_embed_dim=1024, encoder_embed_path=None, encoder_ffn_embed_dim=8192, encoder_layerdrop=0, encoder_layers=6, encoder_layers_to_keep=None, encoder_learned_pos=False, encoder_normalize_before=False, eval_bleu=True, eval_bleu_args='{"beam": 5, "max_len_a": 1.2, "max_len_b": 10}', eval_bleu_detok='moses', eval_bleu_detok_args=None, eval_bleu_print_samples=True, eval_bleu_remove_bpe='@@ ', eval_tokenized_bleu=False, fast_stat_sync=False, find_unused_parameters=False, fix_batches_to_gpus=False, fixed_validation_seed=None, fp16=True, fp16_init_scale=128, fp16_no_flatten_grads=False, fp16_scale_tolerance=0.0, fp16_scale_window=None, keep_best_checkpoints=-1, keep_interval_updates=-1, keep_last_epochs=-1, label_smoothing=0.1, layernorm_embedding=False, left_pad_source='True', left_pad_target='False', load_alignments=False, localsgd_frequency=3, log_format=None, log_interval=100, lr=[0.0005], lr_scheduler='inverse_sqrt', max_epoch=20, max_sentences=None, max_sentences_valid=None, max_source_positions=1024, max_target_positions=1024, max_tokens=4096, max_tokens_valid=4096, max_update=0, maximize_best_checkpoint_metric=False, memory_efficient_bf16=False, memory_efficient_fp16=False, min_loss_scale=0.0001, min_lr=-1, model_parallel_size=1, no_cross_attention=False, no_epoch_checkpoints=True, no_last_checkpoints=False, no_progress_bar=False, no_save=False, no_save_optimizer_state=False, no_scale_embedding=False, no_seed_provided=True, no_token_positional_embeddings=False, nprocs_per_node=1, num_batch_buckets=0, num_workers=1, optimizer='adam', optimizer_overrides='{}', patience=-1, profile=False, quant_noise_pq=0, quant_noise_pq_block_size=8, quant_noise_scalar=0, quantization_config_path=None, required_batch_size_multiple=8, reset_dataloader=True, reset_lr_scheduler=False, reset_meters=False, reset_optimizer=True, restore_file='../../../models/wmt19.de-en.joined-dict.ensemble//model1.pt', save_dir='../checkpoints/EMEA_11_2', save_interval=1, save_interval_updates=0, scoring='bleu', seed=1, sentence_avg=False, share_all_embeddings=False, share_decoder_input_output_embed=True, skip_invalid_size_inputs_valid_test=False, slowmo_algorithm='LocalSGD', slowmo_momentum=None, source_lang=None, stop_time_hours=0, target_lang=None, task='translation', tensorboard_logdir='', threshold_loss_scale=None, tie_adaptive_weights=False, tokenizer=None, tpu=False, train_subset='train', truncate_source=False, update_freq=[1], upsample_primary=1, use_bmuf=False, use_old_adam=False, user_dir=None, valid_subset='valid', validate_after_updates=0, validate_interval=1, validate_interval_updates=0, warmup_init_lr=-1, warmup_updates=4000, weight_decay=0.0)
2021-02-01 00:30:13 | INFO | fairseq.tasks.translation | [de] dictionary: 42024 types
2021-02-01 00:30:13 | INFO | fairseq.tasks.translation | [en] dictionary: 42024 types
2021-02-01 00:30:13 | INFO | fairseq.data.data_utils | loaded 151 examples from: ../../../data-bin/custom_EMEA/orig_EMEA/valid.de-en.de
2021-02-01 00:30:13 | INFO | fairseq.data.data_utils | loaded 151 examples from: ../../../data-bin/custom_EMEA/orig_EMEA/valid.de-en.en
2021-02-01 00:30:13 | INFO | fairseq.tasks.translation | ../../../data-bin/custom_EMEA/orig_EMEA valid de-en 151 examples
2021-02-01 00:30:17 | INFO | fairseq_cli.train | TransformerModel(
  (encoder): TransformerEncoder(
    (dropout_module): FairseqDropout()
    (embed_tokens): Embedding(42024, 1024, padding_idx=1)
    (embed_positions): SinusoidalPositionalEmbedding()
    (layers): ModuleList(
      (0): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (1): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (2): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (3): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (4): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (5): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
    )
  )
  (decoder): TransformerDecoder(
    (dropout_module): FairseqDropout()
    (embed_tokens): Embedding(42024, 1024, padding_idx=1)
    (embed_positions): SinusoidalPositionalEmbedding()
    (layers): ModuleList(
      (0): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (1): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (2): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (3): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (4): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (5): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
    )
    (output_projection): Linear(in_features=1024, out_features=42024, bias=False)
  )
)
2021-02-01 00:30:17 | INFO | fairseq_cli.train | model transformer_vaswani_wmt_en_de_big, criterion LabelSmoothedCrossEntropyCriterion
2021-02-01 00:30:17 | INFO | fairseq_cli.train | num. model params: 312778752 (num. trained: 312778752)
2021-02-01 00:30:22 | INFO | fairseq.trainer | detected shared parameter: decoder.embed_tokens.weight <- decoder.output_projection.weight
2021-02-01 00:30:23 | INFO | fairseq.utils | ***********************CUDA enviroments for all 1 workers***********************
2021-02-01 00:30:23 | INFO | fairseq.utils | rank   0: capabilities =  7.0  ; total memory = 32.000 GB ; name = GRID V100D-32Q                          
2021-02-01 00:30:23 | INFO | fairseq.utils | ***********************CUDA enviroments for all 1 workers***********************
2021-02-01 00:30:23 | INFO | fairseq_cli.train | training on 1 devices (GPUs/TPUs)
2021-02-01 00:30:23 | INFO | fairseq_cli.train | max tokens per GPU = 4096 and max sentences per GPU = None
2021-02-01 00:30:35 | INFO | fairseq.trainer | loaded checkpoint ../../../models/wmt19.de-en.joined-dict.ensemble//model1.pt (epoch 16 @ 0 updates)
2021-02-01 00:30:35 | INFO | fairseq.trainer | loading train data for epoch 1
2021-02-01 00:30:35 | INFO | fairseq.data.data_utils | loaded 10001 examples from: ../../../data-bin/custom_EMEA/orig_EMEA/train.de-en.de
2021-02-01 00:30:35 | INFO | fairseq.data.data_utils | loaded 10001 examples from: ../../../data-bin/custom_EMEA/orig_EMEA/train.de-en.en
2021-02-01 00:30:35 | INFO | fairseq.tasks.translation | ../../../data-bin/custom_EMEA/orig_EMEA train de-en 10001 examples
2021-02-01 00:30:35 | INFO | fairseq_cli.train | begin training epoch 1
2021-02-01 00:30:36 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 64.0
2021-02-01 00:30:36 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 32.0
2021-02-01 00:30:39 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 16.0
2021-02-01 00:30:40 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 8.0
2021-02-01 00:30:54 | INFO | train_inner | epoch 001:    104 / 139 loss=3.56, nll_loss=1.847, ppl=3.6, wps=14213.9, ups=5.76, wpb=2465.8, bsz=72.7, num_updates=100, lr=1.25e-05, gnorm=3.86, loss_scale=12, train_wall=17, wall=31
2021-02-01 00:31:00 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:31:01 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-02-01 00:31:01 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:31:02 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-02-01 00:31:02 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:31:02 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-02-01 00:31:02 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:31:05 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients) .In the studies, Actrapid was compared to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood sugar is regulated.What benefit has actrapid shown in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-02-01 00:31:05 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:31:05 | INFO | valid | epoch 001 | valid on 'valid' subset | loss 3.512 | nll_loss 1.748 | ppl 3.36 | bleu 40.11 | wps 918.7 | wpb 1083 | bsz 37.8 | num_updates 135
2021-02-01 00:31:05 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:31:19 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_11_2/checkpoint_best.pt (epoch 1 @ 135 updates, score 3.512) (writing took 14.418985236436129 seconds)
2021-02-01 00:31:19 | INFO | fairseq_cli.train | end of epoch 1 (average epoch stats below)
2021-02-01 00:31:19 | INFO | train | epoch 001 | loss 3.499 | nll_loss 1.78 | ppl 3.43 | wps 7708.8 | ups 3.13 | wpb 2458.9 | bsz 72.3 | num_updates 135 | lr 1.6875e-05 | gnorm 3.695 | loss_scale 12 | train_wall 24 | wall 57
2021-02-01 00:31:19 | INFO | fairseq_cli.train | begin training epoch 1
2021-02-01 00:31:30 | INFO | train_inner | epoch 002:     65 / 139 loss=3.236, nll_loss=1.481, ppl=2.79, wps=6752.2, ups=2.71, wpb=2487.4, bsz=75, num_updates=200, lr=2.5e-05, gnorm=2.982, loss_scale=8, train_wall=17, wall=68
2021-02-01 00:31:43 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:31:43 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:31:43 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:31:44 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-02-01 00:31:44 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:31:45 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-02-01 00:31:45 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:31:48 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients) .The studies compared Actrapid to a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is regulated.What benefit has Actrapid shown in these studies? HbA1c concentrations have remained relatively stable during the 6 months of treatment with Actrapid.
2021-02-01 00:31:48 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:31:48 | INFO | valid | epoch 002 | valid on 'valid' subset | loss 3.083 | nll_loss 1.259 | ppl 2.39 | bleu 50.45 | wps 872 | wpb 1083 | bsz 37.8 | num_updates 274 | best_loss 3.083
2021-02-01 00:31:48 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:32:06 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_11_2/checkpoint_best.pt (epoch 2 @ 274 updates, score 3.083) (writing took 18.478166620247066 seconds)
2021-02-01 00:32:06 | INFO | fairseq_cli.train | end of epoch 2 (average epoch stats below)
2021-02-01 00:32:06 | INFO | train | epoch 002 | loss 3.153 | nll_loss 1.385 | ppl 2.61 | wps 7285.2 | ups 2.96 | wpb 2458.3 | bsz 71.9 | num_updates 274 | lr 3.425e-05 | gnorm 2.941 | loss_scale 8 | train_wall 23 | wall 103
2021-02-01 00:32:06 | INFO | fairseq_cli.train | begin training epoch 2
2021-02-01 00:32:10 | INFO | train_inner | epoch 003:     26 / 139 loss=3.07, nll_loss=1.288, ppl=2.44, wps=5832.9, ups=2.5, wpb=2333, bsz=67, num_updates=300, lr=3.75e-05, gnorm=2.901, loss_scale=8, train_wall=17, wall=108
2021-02-01 00:32:28 | INFO | train_inner | epoch 003:    126 / 139 loss=2.835, nll_loss=1.021, ppl=2.03, wps=14830.9, ups=5.85, wpb=2535.2, bsz=75.8, num_updates=400, lr=5e-05, gnorm=2.798, loss_scale=8, train_wall=17, wall=125
2021-02-01 00:32:30 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:32:30 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:32:30 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:32:31 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-02-01 00:32:31 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:32:32 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-02-01 00:32:32 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:32:34 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes, in which the pancreas is unable to produce insulin (two studies involving 1,954 patients), and in patients with type 2 diabetes, in which the body cannot process insulin effectively (one study involving 182 patients) .The studies compared Actrapid with a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled.
2021-02-01 00:32:34 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:32:34 | INFO | valid | epoch 003 | valid on 'valid' subset | loss 2.829 | nll_loss 0.948 | ppl 1.93 | bleu 61.65 | wps 998.9 | wpb 1083 | bsz 37.8 | num_updates 413 | best_loss 2.829
2021-02-01 00:32:34 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:32:55 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_11_2/checkpoint_best.pt (epoch 3 @ 413 updates, score 2.829) (writing took 20.81223035324365 seconds)
2021-02-01 00:32:55 | INFO | fairseq_cli.train | end of epoch 3 (average epoch stats below)
2021-02-01 00:32:55 | INFO | train | epoch 003 | loss 2.839 | nll_loss 1.025 | ppl 2.04 | wps 7005.6 | ups 2.85 | wpb 2458.3 | bsz 71.9 | num_updates 413 | lr 5.1625e-05 | gnorm 2.683 | loss_scale 8 | train_wall 23 | wall 152
2021-02-01 00:32:55 | INFO | fairseq_cli.train | begin training epoch 3
2021-02-01 00:33:10 | INFO | train_inner | epoch 004:     87 / 139 loss=2.585, nll_loss=0.738, ppl=1.67, wps=5998.5, ups=2.36, wpb=2538.2, bsz=71, num_updates=500, lr=6.25e-05, gnorm=2.019, loss_scale=8, train_wall=17, wall=167
2021-02-01 00:33:19 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:33:19 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:33:19 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:33:20 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid ist ein rasch wirktigen Insulin und kann zusammen mit langwirkenden Insulinprämien werden werden werden. Actrapide ist ein rasch wirkenden Insulin und kann zusammen mit langwirkenden
2021-02-01 00:33:20 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:33:21 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:33:21 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:33:24 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes, in which the pancreas cannot produce insulin (two studies involving 1,954 patients), and in patients with type 2 diabetes, in which the body cannot process insulin effectively (a study involving 182 patients).
2021-02-01 00:33:24 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:33:24 | INFO | valid | epoch 004 | valid on 'valid' subset | loss 2.723 | nll_loss 0.81 | ppl 1.75 | bleu 73.08 | wps 758.9 | wpb 1083 | bsz 37.8 | num_updates 552 | best_loss 2.723
2021-02-01 00:33:24 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:33:42 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_11_2/checkpoint_best.pt (epoch 4 @ 552 updates, score 2.723) (writing took 18.111428942531347 seconds)
2021-02-01 00:33:42 | INFO | fairseq_cli.train | end of epoch 4 (average epoch stats below)
2021-02-01 00:33:42 | INFO | train | epoch 004 | loss 2.595 | nll_loss 0.749 | ppl 1.68 | wps 7225.9 | ups 2.94 | wpb 2458.3 | bsz 71.9 | num_updates 552 | lr 6.9e-05 | gnorm 2.135 | loss_scale 8 | train_wall 23 | wall 200
2021-02-01 00:33:42 | INFO | fairseq_cli.train | begin training epoch 4
2021-02-01 00:33:51 | INFO | train_inner | epoch 005:     48 / 139 loss=2.542, nll_loss=0.687, ppl=1.61, wps=5922.7, ups=2.46, wpb=2411.9, bsz=72.3, num_updates=600, lr=7.5e-05, gnorm=2.039, loss_scale=8, train_wall=17, wall=208
2021-02-01 00:34:06 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:34:06 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:34:06 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:34:07 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast- acting insulin and can be used in combination with long-acting insulin preparations.
2021-02-01 00:34:07 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:34:08 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:34:08 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:34:10 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients in whom the pancreas cannot produce insulin (two trials involving 1,954 patients) and type 2 diabetes patients in whom the body cannot process insulin effectively (one trial involving 182 patients).
2021-02-01 00:34:10 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:34:10 | INFO | valid | epoch 005 | valid on 'valid' subset | loss 2.693 | nll_loss 0.79 | ppl 1.73 | bleu 75.53 | wps 939.8 | wpb 1083 | bsz 37.8 | num_updates 691 | best_loss 2.693
2021-02-01 00:34:10 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:34:28 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_11_2/checkpoint_best.pt (epoch 5 @ 691 updates, score 2.693) (writing took 18.014979758299887 seconds)
2021-02-01 00:34:28 | INFO | fairseq_cli.train | end of epoch 5 (average epoch stats below)
2021-02-01 00:34:28 | INFO | train | epoch 005 | loss 2.435 | nll_loss 0.567 | ppl 1.48 | wps 7394.8 | ups 3.01 | wpb 2458.3 | bsz 71.9 | num_updates 691 | lr 8.6375e-05 | gnorm 1.834 | loss_scale 8 | train_wall 23 | wall 246
2021-02-01 00:34:28 | INFO | fairseq_cli.train | begin training epoch 5
2021-02-01 00:34:30 | INFO | train_inner | epoch 006:      9 / 139 loss=2.434, nll_loss=0.567, ppl=1.48, wps=6149.3, ups=2.55, wpb=2415.5, bsz=69.1, num_updates=700, lr=8.75e-05, gnorm=2.037, loss_scale=8, train_wall=17, wall=247
2021-02-01 00:34:47 | INFO | train_inner | epoch 006:    109 / 139 loss=2.339, nll_loss=0.46, ppl=1.38, wps=14622.4, ups=5.78, wpb=2527.8, bsz=73.9, num_updates=800, lr=0.0001, gnorm=1.579, loss_scale=8, train_wall=17, wall=265
2021-02-01 00:34:52 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:34:53 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:34:53 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:34:53 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used in combination with long-acting insulin preparations.
2021-02-01 00:34:53 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:34:55 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:34:55 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:34:56 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes, where the pancreas cannot produce insulin (two studies involving 1,954 patients), and in type 2 diabetes, where the body cannot effectively process insulin (one study involving 182 patients), where Actrapide was compared to a human insulin analogue (insulin aspart) by measuring in the blood for six months a substance termed glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
2021-02-01 00:34:56 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:34:56 | INFO | valid | epoch 006 | valid on 'valid' subset | loss 2.671 | nll_loss 0.764 | ppl 1.7 | bleu 78.05 | wps 971.5 | wpb 1083 | bsz 37.8 | num_updates 830 | best_loss 2.671
2021-02-01 00:34:56 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:35:16 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_11_2/checkpoint_best.pt (epoch 6 @ 830 updates, score 2.671) (writing took 19.80754453409463 seconds)
2021-02-01 00:35:16 | INFO | fairseq_cli.train | end of epoch 6 (average epoch stats below)
2021-02-01 00:35:16 | INFO | train | epoch 006 | loss 2.343 | nll_loss 0.465 | ppl 1.38 | wps 7126.9 | ups 2.9 | wpb 2458.3 | bsz 71.9 | num_updates 830 | lr 0.00010375 | gnorm 1.689 | loss_scale 8 | train_wall 23 | wall 294
2021-02-01 00:35:16 | INFO | fairseq_cli.train | begin training epoch 6
2021-02-01 00:35:28 | INFO | train_inner | epoch 007:     70 / 139 loss=2.308, nll_loss=0.427, ppl=1.34, wps=5642, ups=2.45, wpb=2306.6, bsz=69, num_updates=900, lr=0.0001125, gnorm=1.612, loss_scale=8, train_wall=16, wall=305
2021-02-01 00:35:40 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:35:41 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:35:41 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:35:41 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast- and long-acting insulin that can be used in conjunction with long-acting insulin preparations.
2021-02-01 00:35:41 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:35:43 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:35:43 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:35:45 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes, when the pancreas cannot produce insulin (two studies involving 1,954 patients), and in type 2 diabetes, when the body cannot effectively process insulin (a study involving 182 patients).
2021-02-01 00:35:45 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:35:45 | INFO | valid | epoch 007 | valid on 'valid' subset | loss 2.705 | nll_loss 0.798 | ppl 1.74 | bleu 78.13 | wps 852.5 | wpb 1083 | bsz 37.8 | num_updates 969 | best_loss 2.671
2021-02-01 00:35:45 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:35:54 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_11_2/checkpoint_last.pt (epoch 7 @ 969 updates, score 2.705) (writing took 8.658221669495106 seconds)
2021-02-01 00:35:54 | INFO | fairseq_cli.train | end of epoch 7 (average epoch stats below)
2021-02-01 00:35:54 | INFO | train | epoch 007 | loss 2.288 | nll_loss 0.405 | ppl 1.32 | wps 9161.8 | ups 3.73 | wpb 2458.3 | bsz 71.9 | num_updates 969 | lr 0.000121125 | gnorm 1.603 | loss_scale 8 | train_wall 23 | wall 331
2021-02-01 00:35:54 | INFO | fairseq_cli.train | begin training epoch 7
2021-02-01 00:35:59 | INFO | train_inner | epoch 008:     31 / 139 loss=2.269, nll_loss=0.386, ppl=1.31, wps=8355.9, ups=3.23, wpb=2584.4, bsz=78.4, num_updates=1000, lr=0.000125, gnorm=1.427, loss_scale=8, train_wall=17, wall=336
2021-02-01 00:36:16 | INFO | train_inner | epoch 008:    131 / 139 loss=2.262, nll_loss=0.378, ppl=1.3, wps=14301, ups=5.83, wpb=2451.8, bsz=69.4, num_updates=1100, lr=0.0001375, gnorm=1.545, loss_scale=8, train_wall=17, wall=353
2021-02-01 00:36:17 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:36:18 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:36:18 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:36:19 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used in combination with long-acting insulin preparations.
2021-02-01 00:36:19 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:36:20 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:36:20 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:36:22 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients whose pancreas cannot produce insulin (two studies involving 1,954 patients) and type 2 diabetes patients whose bodies cannot process insulin effectively (one study involving 182 patients). In the studies, Actrapide was compared to a human insulin analogue (insulin Aspart) by measuring in the blood a substance termed glycosylated haemoglobin (HbA1c) for six months to see how well the blood glucose is controlled.
2021-02-01 00:36:22 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:36:22 | INFO | valid | epoch 008 | valid on 'valid' subset | loss 2.72 | nll_loss 0.815 | ppl 1.76 | bleu 77.74 | wps 865.9 | wpb 1083 | bsz 37.8 | num_updates 1108 | best_loss 2.671
2021-02-01 00:36:22 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:36:30 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_11_2/checkpoint_last.pt (epoch 8 @ 1108 updates, score 2.72) (writing took 7.283615452237427 seconds)
2021-02-01 00:36:30 | INFO | fairseq_cli.train | end of epoch 8 (average epoch stats below)
2021-02-01 00:36:30 | INFO | train | epoch 008 | loss 2.256 | nll_loss 0.37 | ppl 1.29 | wps 9511 | ups 3.87 | wpb 2458.3 | bsz 71.9 | num_updates 1108 | lr 0.0001385 | gnorm 1.868 | loss_scale 8 | train_wall 24 | wall 367
2021-02-01 00:36:30 | INFO | fairseq_cli.train | begin training epoch 8
2021-02-01 00:36:45 | INFO | train_inner | epoch 009:     92 / 139 loss=2.261, nll_loss=0.377, ppl=1.3, wps=8221.9, ups=3.43, wpb=2396, bsz=67.8, num_updates=1200, lr=0.00015, gnorm=2.406, loss_scale=8, train_wall=17, wall=383
2021-02-01 00:36:53 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:36:54 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:36:54 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:36:55 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be given in combination with long-acting insulin preparations.
2021-02-01 00:36:55 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:36:56 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:36:56 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:36:58 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients who cannot produce insulin (two studies involving 1,954 patients) and in type 2 diabetes patients in whom the body cannot process insulin effectively (one study involving 182 patients).
2021-02-01 00:36:58 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:36:58 | INFO | valid | epoch 009 | valid on 'valid' subset | loss 2.752 | nll_loss 0.851 | ppl 1.8 | bleu 78.78 | wps 901.2 | wpb 1083 | bsz 37.8 | num_updates 1247 | best_loss 2.671
2021-02-01 00:36:58 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:37:06 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_11_2/checkpoint_last.pt (epoch 9 @ 1247 updates, score 2.752) (writing took 7.678300105035305 seconds)
2021-02-01 00:37:06 | INFO | fairseq_cli.train | end of epoch 9 (average epoch stats below)
2021-02-01 00:37:06 | INFO | train | epoch 009 | loss 2.245 | nll_loss 0.36 | ppl 1.28 | wps 9426.4 | ups 3.83 | wpb 2458.3 | bsz 71.9 | num_updates 1247 | lr 0.000155875 | gnorm 1.724 | loss_scale 8 | train_wall 24 | wall 403
2021-02-01 00:37:06 | INFO | fairseq_cli.train | begin training epoch 9
2021-02-01 00:37:15 | INFO | train_inner | epoch 010:     53 / 139 loss=2.207, nll_loss=0.32, ppl=1.25, wps=8346.2, ups=3.37, wpb=2473.2, bsz=73.2, num_updates=1300, lr=0.0001625, gnorm=1.409, loss_scale=8, train_wall=17, wall=412
2021-02-01 00:37:30 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:37:30 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:37:30 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:37:31 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-02-01 00:37:31 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:37:32 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:37:32 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:37:35 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes, when the pancreas cannot produce insulin (two studies involving 1,954 patients), and in patients with type 2 diabetes, when the body cannot process insulin effectively (a study involving 182 patients), when Actrapide was compared with a human insulin analogue (insulin aspart) by measuring for six months the concentration of a substance termed glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
2021-02-01 00:37:35 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:37:35 | INFO | valid | epoch 010 | valid on 'valid' subset | loss 2.741 | nll_loss 0.824 | ppl 1.77 | bleu 77.82 | wps 832.2 | wpb 1083 | bsz 37.8 | num_updates 1386 | best_loss 2.671
2021-02-01 00:37:35 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:37:48 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_11_2/checkpoint_last.pt (epoch 10 @ 1386 updates, score 2.741) (writing took 13.478745328262448 seconds)
2021-02-01 00:37:48 | INFO | fairseq_cli.train | end of epoch 10 (average epoch stats below)
2021-02-01 00:37:48 | INFO | train | epoch 010 | loss 2.212 | nll_loss 0.325 | ppl 1.25 | wps 8064.9 | ups 3.28 | wpb 2458.3 | bsz 71.9 | num_updates 1386 | lr 0.00017325 | gnorm 1.467 | loss_scale 8 | train_wall 24 | wall 446
2021-02-01 00:37:48 | INFO | fairseq_cli.train | begin training epoch 10
2021-02-01 00:37:51 | INFO | train_inner | epoch 011:     14 / 139 loss=2.226, nll_loss=0.339, ppl=1.27, wps=7014, ups=2.8, wpb=2507.6, bsz=71.6, num_updates=1400, lr=0.000175, gnorm=1.568, loss_scale=8, train_wall=17, wall=448
2021-02-01 00:38:07 | INFO | train_inner | epoch 011:    114 / 139 loss=2.213, nll_loss=0.325, ppl=1.25, wps=14228.3, ups=5.94, wpb=2396.5, bsz=73.5, num_updates=1500, lr=0.0001875, gnorm=1.577, loss_scale=8, train_wall=17, wall=465
2021-02-01 00:38:12 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:38:13 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:38:13 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:38:14 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used together with long- acting insulin preparations.
2021-02-01 00:38:14 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:38:15 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:38:15 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:38:17 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide was used in type 1 diabetes patients whose pancreas cannot produce insulin (two studies involving 1,954 patients) and in type 2 diabetes patients in whom their body cannot process insulin effectively (a study involving 182 patients). In the studies, Actrapide was compared with an analogue human insulin by measuring the level of a substance termed glycosylated haemoglobin (HbA1c) in the blood, which gives an indication of how well the blood sugar is controlled.
2021-02-01 00:38:17 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:38:17 | INFO | valid | epoch 011 | valid on 'valid' subset | loss 2.8 | nll_loss 0.904 | ppl 1.87 | bleu 76.02 | wps 912.4 | wpb 1083 | bsz 37.8 | num_updates 1525 | best_loss 2.671
2021-02-01 00:38:17 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:38:24 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_11_2/checkpoint_last.pt (epoch 11 @ 1525 updates, score 2.8) (writing took 7.055118856020272 seconds)
2021-02-01 00:38:24 | INFO | fairseq_cli.train | end of epoch 11 (average epoch stats below)
2021-02-01 00:38:24 | INFO | train | epoch 011 | loss 2.217 | nll_loss 0.33 | ppl 1.26 | wps 9583.8 | ups 3.9 | wpb 2458.3 | bsz 71.9 | num_updates 1525 | lr 0.000190625 | gnorm 1.618 | loss_scale 8 | train_wall 23 | wall 481
2021-02-01 00:38:24 | INFO | fairseq_cli.train | begin training epoch 11
2021-02-01 00:38:37 | INFO | train_inner | epoch 012:     75 / 139 loss=2.198, nll_loss=0.31, ppl=1.24, wps=8701.2, ups=3.42, wpb=2547.2, bsz=72.2, num_updates=1600, lr=0.0002, gnorm=1.557, loss_scale=8, train_wall=17, wall=494
2021-02-01 00:38:48 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:38:48 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:38:48 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:38:49 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be administered together with long-acting insulin preparations.
2021-02-01 00:38:49 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:38:50 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:38:50 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:38:53 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetic patients who the pancreas cannot produce insulin (two studies of 1,954 patients) and type 2 diabetic patients who the body cannot process insulin effectively (one study of 182 patients). The studies compared Actrapide to a human insulin analogue (insulin aspart) by measuring the level of a substance termed glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
2021-02-01 00:38:53 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:38:53 | INFO | valid | epoch 012 | valid on 'valid' subset | loss 2.778 | nll_loss 0.889 | ppl 1.85 | bleu 75.89 | wps 774.7 | wpb 1083 | bsz 37.8 | num_updates 1664 | best_loss 2.671
2021-02-01 00:38:53 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:39:06 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_11_2/checkpoint_last.pt (epoch 12 @ 1664 updates, score 2.778) (writing took 12.749613371677697 seconds)
2021-02-01 00:39:06 | INFO | fairseq_cli.train | end of epoch 12 (average epoch stats below)
2021-02-01 00:39:06 | INFO | train | epoch 012 | loss 2.2 | nll_loss 0.312 | ppl 1.24 | wps 8127.2 | ups 3.31 | wpb 2458.3 | bsz 71.9 | num_updates 1664 | lr 0.000208 | gnorm 1.548 | loss_scale 8 | train_wall 24 | wall 523
2021-02-01 00:39:06 | INFO | fairseq_cli.train | begin training epoch 12
2021-02-01 00:39:12 | INFO | train_inner | epoch 013:     36 / 139 loss=2.218, nll_loss=0.332, ppl=1.26, wps=6820.9, ups=2.83, wpb=2411.6, bsz=73.8, num_updates=1700, lr=0.0002125, gnorm=1.69, loss_scale=8, train_wall=17, wall=530
2021-02-01 00:39:29 | INFO | train_inner | epoch 013:    136 / 139 loss=2.195, nll_loss=0.305, ppl=1.24, wps=14319, ups=5.8, wpb=2466.8, bsz=70.3, num_updates=1800, lr=0.000225, gnorm=1.47, loss_scale=8, train_wall=17, wall=547
2021-02-01 00:39:30 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:39:31 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:39:31 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:39:32 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-02-01 00:39:32 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:39:33 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:39:33 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:39:35 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide was studied in type 1 diabetes patients who cannot produce insulin (two studies involving 1,954 patients) and type 2 diabetes patients who the body cannot process insulin effectively (one study involving 182 patients) The studies compared Actrapide with analogue human insulin (insulin aspart) by measuring the level in blood of a substance called glycosylated haemoglobin (HbA1c) over six months, which gives an indication of how well the blood glucose is controlled.
2021-02-01 00:39:35 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:39:35 | INFO | valid | epoch 013 | valid on 'valid' subset | loss 2.789 | nll_loss 0.916 | ppl 1.89 | bleu 76.39 | wps 851.4 | wpb 1083 | bsz 37.8 | num_updates 1803 | best_loss 2.671
2021-02-01 00:39:35 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:39:46 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_11_2/checkpoint_last.pt (epoch 13 @ 1803 updates, score 2.789) (writing took 11.270594304427505 seconds)
2021-02-01 00:39:46 | INFO | fairseq_cli.train | end of epoch 13 (average epoch stats below)
2021-02-01 00:39:46 | INFO | train | epoch 013 | loss 2.202 | nll_loss 0.313 | ppl 1.24 | wps 8471.6 | ups 3.45 | wpb 2458.3 | bsz 71.9 | num_updates 1803 | lr 0.000225375 | gnorm 1.572 | loss_scale 8 | train_wall 24 | wall 564
2021-02-01 00:39:46 | INFO | fairseq_cli.train | begin training epoch 13
2021-02-01 00:40:03 | INFO | train_inner | epoch 014:     97 / 139 loss=2.21, nll_loss=0.323, ppl=1.25, wps=7466.7, ups=2.97, wpb=2515.9, bsz=73, num_updates=1900, lr=0.0002375, gnorm=1.765, loss_scale=8, train_wall=17, wall=580
2021-02-01 00:40:10 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:40:11 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:40:11 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:40:12 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin that can be used concomitantly with long- acting insulin preparations.
2021-02-01 00:40:12 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:40:13 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:40:13 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:40:15 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetic patients, when the pancreas cannot produce insulin (two studies involving 1,954 patients) and in type 2 diabetic patients, when the body cannot effectively process insulin (a study involving 182 patients) and in the studies, Actrapide was compared to an analogue human insulin (insulin aspart) when given glycosylated haemoglobin (HbA1c), indicating how well the blood glucose is controlled.
2021-02-01 00:40:15 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:40:15 | INFO | valid | epoch 014 | valid on 'valid' subset | loss 2.813 | nll_loss 0.933 | ppl 1.91 | bleu 74.94 | wps 865.3 | wpb 1083 | bsz 37.8 | num_updates 1942 | best_loss 2.671
2021-02-01 00:40:15 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:40:23 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_11_2/checkpoint_last.pt (epoch 14 @ 1942 updates, score 2.813) (writing took 7.685012431815267 seconds)
2021-02-01 00:40:23 | INFO | fairseq_cli.train | end of epoch 14 (average epoch stats below)
2021-02-01 00:40:23 | INFO | train | epoch 014 | loss 2.218 | nll_loss 0.33 | ppl 1.26 | wps 9357.9 | ups 3.81 | wpb 2458.3 | bsz 71.9 | num_updates 1942 | lr 0.00024275 | gnorm 1.805 | loss_scale 8 | train_wall 24 | wall 600
2021-02-01 00:40:23 | INFO | fairseq_cli.train | begin training epoch 14
2021-02-01 00:40:33 | INFO | train_inner | epoch 015:     58 / 139 loss=2.218, nll_loss=0.332, ppl=1.26, wps=8194.8, ups=3.36, wpb=2439, bsz=72.1, num_updates=2000, lr=0.00025, gnorm=1.814, loss_scale=8, train_wall=17, wall=610
2021-02-01 00:40:47 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:40:47 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:40:47 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:40:48 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be administered together with long-acting insulin preparations.
2021-02-01 00:40:48 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:40:49 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:40:49 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:40:51 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients who cannot produce insulin (two studies involving 1,954 patients) and in type 2 diabetes patients, in whom the body cannot process insulin effectively (a study involving 182 patients) and the studies compared Actrapide to an analogue human insulin (aspart), where it measured for six months the level of a substance called glycosylated haemoglobin (HbA1c) in the blood, which gives an indication of how well the blood glucose is controlled.
2021-02-01 00:40:51 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:40:51 | INFO | valid | epoch 015 | valid on 'valid' subset | loss 2.855 | nll_loss 0.975 | ppl 1.97 | bleu 74.43 | wps 883.7 | wpb 1083 | bsz 37.8 | num_updates 2081 | best_loss 2.671
2021-02-01 00:40:51 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:41:00 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_11_2/checkpoint_last.pt (epoch 15 @ 2081 updates, score 2.855) (writing took 8.610398606397212 seconds)
2021-02-01 00:41:00 | INFO | fairseq_cli.train | end of epoch 15 (average epoch stats below)
2021-02-01 00:41:00 | INFO | train | epoch 015 | loss 2.226 | nll_loss 0.341 | ppl 1.27 | wps 9133.3 | ups 3.72 | wpb 2458.3 | bsz 71.9 | num_updates 2081 | lr 0.000260125 | gnorm 1.856 | loss_scale 8 | train_wall 24 | wall 637
2021-02-01 00:41:00 | INFO | fairseq_cli.train | begin training epoch 15
2021-02-01 00:41:03 | INFO | train_inner | epoch 016:     19 / 139 loss=2.238, nll_loss=0.353, ppl=1.28, wps=7885, ups=3.26, wpb=2416.4, bsz=67.3, num_updates=2100, lr=0.0002625, gnorm=1.919, loss_scale=8, train_wall=17, wall=641
2021-02-01 00:41:21 | INFO | train_inner | epoch 016:    119 / 139 loss=2.203, nll_loss=0.317, ppl=1.25, wps=14461.2, ups=5.79, wpb=2496.3, bsz=74.5, num_updates=2200, lr=0.000275, gnorm=1.656, loss_scale=8, train_wall=17, wall=658
2021-02-01 00:41:24 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:41:25 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:41:25 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:41:26 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used with long-acting insulin preparations.
2021-02-01 00:41:26 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:41:27 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:41:27 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:41:29 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetic patients, for whom the pancreas cannot produce insulin (two studies involving 1,954 patients) and in type 2 diabetic patients, for whom the body cannot process insulin effectively (a study involving 182 patients). Actrapide was compared with a human insulin analogue (insulin aspart) during six months, when it was measured in the blood as a glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
2021-02-01 00:41:29 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:41:29 | INFO | valid | epoch 016 | valid on 'valid' subset | loss 2.838 | nll_loss 0.974 | ppl 1.96 | bleu 73.94 | wps 812.6 | wpb 1083 | bsz 37.8 | num_updates 2220 | best_loss 2.671
2021-02-01 00:41:29 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:41:37 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_11_2/checkpoint_last.pt (epoch 16 @ 2220 updates, score 2.838) (writing took 7.473462855443358 seconds)
2021-02-01 00:41:37 | INFO | fairseq_cli.train | end of epoch 16 (average epoch stats below)
2021-02-01 00:41:37 | INFO | train | epoch 016 | loss 2.211 | nll_loss 0.325 | ppl 1.25 | wps 9308.4 | ups 3.79 | wpb 2458.3 | bsz 71.9 | num_updates 2220 | lr 0.0002775 | gnorm 1.695 | loss_scale 8 | train_wall 24 | wall 674
2021-02-01 00:41:37 | INFO | fairseq_cli.train | begin training epoch 16
2021-02-01 00:41:51 | INFO | train_inner | epoch 017:     80 / 139 loss=2.214, nll_loss=0.326, ppl=1.25, wps=8108.2, ups=3.34, wpb=2431.2, bsz=67.6, num_updates=2300, lr=0.0002875, gnorm=1.777, loss_scale=8, train_wall=17, wall=688
2021-02-01 00:42:01 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:42:01 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:42:01 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:42:02 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used with long-acting insulin preparations.
2021-02-01 00:42:02 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:42:04 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:42:04 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:42:06 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetic patients who the pancreas cannot produce insulin (two studies involving 1,954 patients) and in type 2 diabetic patients for whom the body is not effectively using insulin (one study involving 182 patients) The studies compared Actrapide with analogue human insulin (insulin) when given for six months as a glycosylated haemoglobin (HbA1c), which gives a measure of how well the blood glucose is controlled.
2021-02-01 00:42:06 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:42:06 | INFO | valid | epoch 017 | valid on 'valid' subset | loss 2.86 | nll_loss 1.005 | ppl 2.01 | bleu 75.29 | wps 898.9 | wpb 1083 | bsz 37.8 | num_updates 2359 | best_loss 2.671
2021-02-01 00:42:06 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:42:13 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_11_2/checkpoint_last.pt (epoch 17 @ 2359 updates, score 2.86) (writing took 7.580225038342178 seconds)
2021-02-01 00:42:13 | INFO | fairseq_cli.train | end of epoch 17 (average epoch stats below)
2021-02-01 00:42:13 | INFO | train | epoch 017 | loss 2.21 | nll_loss 0.322 | ppl 1.25 | wps 9400.9 | ups 3.82 | wpb 2458.3 | bsz 71.9 | num_updates 2359 | lr 0.000294875 | gnorm 1.687 | loss_scale 8 | train_wall 24 | wall 711
2021-02-01 00:42:13 | INFO | fairseq_cli.train | begin training epoch 17
2021-02-01 00:42:20 | INFO | train_inner | epoch 018:     41 / 139 loss=2.218, nll_loss=0.329, ppl=1.26, wps=8296.8, ups=3.38, wpb=2457.9, bsz=79, num_updates=2400, lr=0.0003, gnorm=1.786, loss_scale=8, train_wall=17, wall=718
2021-02-01 00:42:37 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:42:38 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:42:38 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:42:39 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-02-01 00:42:39 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:42:40 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:42:40 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:42:42 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients who the pancreas cannot produce insulin (two studies in 1,954 patients) or in type 2 diabetes patients who need insulin (a study in 182 patients).
2021-02-01 00:42:42 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:42:42 | INFO | valid | epoch 018 | valid on 'valid' subset | loss 2.864 | nll_loss 1.003 | ppl 2 | bleu 73.23 | wps 879.5 | wpb 1083 | bsz 37.8 | num_updates 2498 | best_loss 2.671
2021-02-01 00:42:42 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:42:50 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_11_2/checkpoint_last.pt (epoch 18 @ 2498 updates, score 2.864) (writing took 8.264746721833944 seconds)
2021-02-01 00:42:50 | INFO | fairseq_cli.train | end of epoch 18 (average epoch stats below)
2021-02-01 00:42:50 | INFO | train | epoch 018 | loss 2.225 | nll_loss 0.338 | ppl 1.26 | wps 9202.1 | ups 3.74 | wpb 2458.3 | bsz 71.9 | num_updates 2498 | lr 0.00031225 | gnorm 1.844 | loss_scale 8 | train_wall 24 | wall 748
2021-02-01 00:42:50 | INFO | fairseq_cli.train | begin training epoch 18
2021-02-01 00:42:51 | INFO | train_inner | epoch 019:      2 / 139 loss=2.223, nll_loss=0.337, ppl=1.26, wps=8029.5, ups=3.29, wpb=2439.4, bsz=69.4, num_updates=2500, lr=0.0003125, gnorm=1.706, loss_scale=8, train_wall=17, wall=748
2021-02-01 00:42:54 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 4.0
2021-02-01 00:43:08 | INFO | train_inner | epoch 019:    103 / 139 loss=2.257, nll_loss=0.375, ppl=1.3, wps=14560.2, ups=5.69, wpb=2558.3, bsz=73.9, num_updates=2600, lr=0.000325, gnorm=2.099, loss_scale=5, train_wall=17, wall=766
2021-02-01 00:43:14 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:43:15 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:43:15 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:43:16 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used together with longstanding insulin supplements.
2021-02-01 00:43:16 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:43:17 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:43:17 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:43:19 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide was studied in type 1 diabetes, when the pancreas cannot produce insulin (two studies involving 1,954 patients) or in type 2 diabetes, when the body cannot process insulin effectively (a study of 182 patients). In the studies, Actrapide was compared with a human insulin analogue (insulin aspart), as measured by the levels of a substance called glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
2021-02-01 00:43:19 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:43:19 | INFO | valid | epoch 019 | valid on 'valid' subset | loss 2.88 | nll_loss 0.997 | ppl 2 | bleu 76.08 | wps 842.4 | wpb 1083 | bsz 37.8 | num_updates 2636 | best_loss 2.671
2021-02-01 00:43:19 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:43:31 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_11_2/checkpoint_last.pt (epoch 19 @ 2636 updates, score 2.88) (writing took 11.961838352493942 seconds)
2021-02-01 00:43:31 | INFO | fairseq_cli.train | end of epoch 19 (average epoch stats below)
2021-02-01 00:43:31 | INFO | train | epoch 019 | loss 2.248 | nll_loss 0.364 | ppl 1.29 | wps 8336.3 | ups 3.37 | wpb 2471.8 | bsz 72.5 | num_updates 2636 | lr 0.0003295 | gnorm 2.055 | loss_scale 5 | train_wall 24 | wall 789
2021-02-01 00:43:31 | INFO | fairseq_cli.train | begin training epoch 19
2021-02-01 00:43:42 | INFO | train_inner | epoch 020:     64 / 139 loss=2.221, nll_loss=0.334, ppl=1.26, wps=6938, ups=2.93, wpb=2364.7, bsz=73.9, num_updates=2700, lr=0.0003375, gnorm=2.339, loss_scale=4, train_wall=17, wall=800
2021-02-01 00:43:55 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:43:56 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:43:56 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:43:57 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-02-01 00:43:57 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:43:58 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:43:58 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:44:00 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes, where the pancreas cannot produce insulin (two studies involving 1,954 patients) or type 2 diabetes, where the body cannot effectively process type 2 diabetes, and the Actrapide studies compared Actrapide with a human insulin analogue (two studies involving 1,954 patients) by keeping the level of a substance termed glycosylated haemoglobin (HbA1c) under control for six months.
2021-02-01 00:44:00 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:44:00 | INFO | valid | epoch 020 | valid on 'valid' subset | loss 2.924 | nll_loss 1.042 | ppl 2.06 | bleu 75.23 | wps 921 | wpb 1083 | bsz 37.8 | num_updates 2775 | best_loss 2.671
2021-02-01 00:44:00 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:44:09 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_11_2/checkpoint_last.pt (epoch 20 @ 2775 updates, score 2.924) (writing took 9.097839642316103 seconds)
2021-02-01 00:44:09 | INFO | fairseq_cli.train | end of epoch 20 (average epoch stats below)
2021-02-01 00:44:09 | INFO | train | epoch 020 | loss 2.26 | nll_loss 0.375 | ppl 1.3 | wps 9036 | ups 3.68 | wpb 2458.3 | bsz 71.9 | num_updates 2775 | lr 0.000346875 | gnorm 3.218 | loss_scale 4 | train_wall 24 | wall 826
2021-02-01 00:44:09 | INFO | fairseq_cli.train | done training in 813.7 seconds


###############################################################################
Peregrine Cluster
Job 17761740 for user 's3475743'
Finished at: Mon Feb  1 00:44:12 CET 2021

Job details:
============

Job ID              : 17761740
Name                : EMEA_11_2
User                : s3475743
Partition           : gpu
Nodes               : pg-gpu28
Number of Nodes     : 1
Cores               : 12
State               : COMPLETED
Submit              : 2021-01-31T22:39:21
Start               : 2021-02-01T00:30:03
End                 : 2021-02-01T00:44:12
Reserved walltime   : 23:55:00
Used walltime       : 00:14:09
Used CPU time       : 00:13:27 (efficiency:  7.92%)
% User (Computation): 60.88%
% System (I/O)      : 39.12%
Mem reserved        : 32G/node
Max Mem used        : 5.61G (pg-gpu28)
Max Disk Write      : 40.96K (pg-gpu28)
Max Disk Read       : 2.30M (pg-gpu28)
Average GPU usage   : 54.3% (pg-gpu28)


Acknowledgements:
=================

Please see this page for information about acknowledging Peregrine in your publications:

https://wiki.hpc.rug.nl/peregrine/introduction/scientific_output

################################################################################
